Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

NCT00003449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: dexamethasone
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel

Sponsor

University of Southern California

Collaborators

[object Object]